>>> CRDA LN -7.5% on numbers - Stock trading on strong support & Still M&A target in the Spec. Chemicals...
Syngenta news today can give ideas to US players inthe sector...(IFF, Dupont Dow, Ashland...)
Exane comment on note from the 6th of June :
Croda: the stock has recently de-rated on short-term concerns, whilst peers have
re-rated; many cash-rich global majors want speciality/consumer businesses, including
Dow, DuPont and Ashland. A tax inversion scheme with the latter cannot be excluded
(too small for the others). IFF has also explained they are looking at 'adjacent' markets.
Croda could thus be a potential target (inversion scheme could also be an option given
their relative size). However, IFF would need a partner to buy the cyclical pieces
(Performance Technologies and Industrial Chemicals).
--> Could make sens to start looking at it regarding the Performance vs Peers.
{CRDA LN Equity BAS GY Equity GRT D}
